PODNL1 and cancer: The GSEA confirmed that PONDL1 expressions significantly positively correlated with the pathways in cancers and focal adhesion in six types of cancers including LGG, GBM, KIRC, BLCA, KIRP and OV, which all exhibited a poor prognosis in the PODNL1 high expression groups (Figure 9B–G).